Viewing Study NCT06729593


Ignite Creation Date: 2025-12-25 @ 1:22 AM
Ignite Modification Date: 2026-04-09 @ 9:59 AM
Study NCT ID: NCT06729593
Status: COMPLETED
Last Update Posted: 2025-10-09
First Post: 2024-12-10
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Remdesivir for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization: